E-Pharmacy Market By Region- Global Industry Analysis and Forecast to 2027

Table of Contents

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       E-Pharmacy Market, By Product Type

5.1.     Introduction

5.2.     Global E-Pharmacy Revenue and Market Share by Product Type (2017-2027)

5.2.1.  Global E-Pharmacy Revenue and Revenue Share by Product Type (2017-2027)

5.3.     OTC Drugs

5.3.1.  Global OTC Drugs Revenue and Growth Rate (2017-2027)

5.4.     Prescription Drugs

5.4.1.  Global Prescription Drugs Revenue and Growth Rate (2017-2027)

6.       E-Pharmacy Market, By Region

6.1.     Introduction

6.2.     Global E-Pharmacy Revenue and Market Share by Regions

6.2.1.  Global E-Pharmacy Revenue by Regions (2017-2027)

6.3.     North America E-Pharmacy by Countries

6.3.1.  North America E-Pharmacy Revenue and Growth Rate (2017-2027)

6.3.2.  North America E-Pharmacy Revenue (Million USD) by Countries (2017-2027)

6.3.3.  United States

6.3.3.1.  United States E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

6.3.4.  Canada

6.3.4.1.  Canada E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

6.3.5.  Mexico

6.3.5.1.  Mexico E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.     Europe E-Pharmacy by Countries

6.4.1.  Europe E-Pharmacy Revenue and Growth Rate (2017-2027)

6.4.2.  Europe E-Pharmacy Revenue (Million USD) by Countries (2017-2027)

6.4.3.  Germany

6.4.3.1.  Germany E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.4.  France

6.4.4.1.  France E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.5.  UK

6.4.5.1.  UK E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.6.  Russia

6.4.6.1.  Russia E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.7.  Italy

6.4.7.1.  Italy E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.8.  Rest of Europe

6.4.8.1.  Rest of Europe E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.     Asia-Pacific E-Pharmacy by Countries

6.5.1.  Asia-Pacific E-Pharmacy Revenue and Growth Rate (2017-2027)

6.5.2.  Asia-Pacific E-Pharmacy Revenue (Million USD) by Countries (2017-2027)

6.5.3.  China

6.5.3.1.  China E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.4.  Japan

6.5.4.1.  Japan E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.5.  Korea

6.5.5.1.  Korea E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.6.  India

6.5.6.1.  India E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.7.  Southeast Asia

6.5.7.1.  Southeast Asia E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.8.  Rest of Asia-Pacific

6.5.8.1.  Rest of Asia-Pacific E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.     South America E-Pharmacy by Countries

6.6.1.  South America E-Pharmacy Revenue and Growth Rate (2017-2027)

6.6.2.  South America E-Pharmacy Revenue (Million USD) by Countries (2017-2027)

6.6.3.  Brazil

6.6.3.1.  Brazil E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.4.  Argentina

6.6.4.1.  Argentina E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.5.  Columbia

6.6.5.1.  Columbia E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.6.  Rest of South America

6.6.6.1.  Rest of South America E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.     Middle East and Africa E-Pharmacy by Countries

6.7.1.  Middle East and Africa E-Pharmacy Revenue and Growth Rate (2017-2027)

6.7.2.  Middle East and Africa E-Pharmacy Revenue (Million USD) by Countries (2017-2027)

6.7.3.  Saudi Arabia

6.7.3.1.  Saudi Arabia E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.4.  United Arab Emirates

6.7.4.1.  United Arab Emirates E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.5.  Egypt

6.7.5.1.  Egypt E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.6.  Nigeria

6.7.6.1.  Nigeria E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.7.  South Africa

6.7.7.1.  South Africa E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.8.  Turkey

6.7.8.1.  Turkey E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.9.  Rest of Middle East and Africa

6.7.9.1.  Rest of Middle East and Africa E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

7.       Company Profiles

7.1.     The Kroger Co.

7.1.1.  Business Overview

7.1.2.   Service Portfolio

7.1.3.  Strategic Developments

7.1.4.  Financial Overview

7.2.     Walgreen Co.

7.2.1.  Business Overview

7.2.2.   Service Portfolio

7.2.3.  Strategic Developments

7.2.4.  Financial Overview

7.3.     Giant Eagle, Inc.

7.3.1.  Business Overview

7.3.2.   Service Portfolio

7.3.3.  Strategic Developments

7.3.4.  Financial Overview

7.4.     Walmart Stores, Inc.

7.4.1.  Business Overview

7.4.2.   Service Portfolio

7.4.3.  Strategic Developments

7.4.4.  Financial Overview

7.5.     Express Scripts Holding Company

7.5.1.  Business Overview

7.5.2.   Service Portfolio

7.5.3.  Strategic Developments

7.5.4.  Financial Overview

7.6.     CVS Health

7.6.1.  Business Overview

7.6.2.   Service Portfolio

7.6.3.  Strategic Developments

7.6.4.  Financial Overview

7.7.     Optum Rx, Inc.

7.7.1.  Business Overview

7.7.2.   Service Portfolio

7.7.3.  Strategic Developments

7.7.4.  Financial Overview

7.8.     Rowlands Pharmacy

7.8.1.  Business Overview

7.8.2.   Service Portfolio

7.8.3.  Strategic Developments

7.8.4.  Financial Overview

7.9.     DocMorris (Zur Rose Group AG)

7.9.1.  Business Overview

7.9.2.   Service Portfolio

7.9.3.  Strategic Developments

7.9.4.  Financial Overview

7.10. 1mg

7.10.1.      Business Overview

7.10.2.       Service Portfolio

7.10.3.      Strategic Developments

7.10.4.      Financial Overview

7.11. Netmeds

7.11.1.      Business Overview

7.11.2.       Service Portfolio

7.11.3.      Strategic Developments

7.11.4.      Financial Overview

7.12. Zur Rose Group AG

7.12.1.      Business Overview

7.12.2.       Service Portfolio

7.12.3.      Strategic Developments

7.12.4.      Financial Overview

8.       Global E-Pharmacy Market Competition, by Manufacturer

8.1.     Global E-Pharmacy Revenue and Market Share by Manufacturer (2017-2017)

8.2.     Top 5 E-Pharmacy Manufacturer Market Share

9.       E-Pharmacy Market Forecast (2017-2027)

9.1.     Global E-Pharmacy Revenue (Millions USD) and Growth Rate (2017-2027)

9.2.     E-Pharmacy Market Forecast by Regions (2017-2027)

9.2.1.  North America E-Pharmacy Market Forecast (2017-2027)

9.2.1.1.  United States E-Pharmacy Market Forecast (2017-2027)

9.2.1.2.  Canada E-Pharmacy Market Forecast (2017-2027)

9.2.1.3.  Mexico E-Pharmacy Market Forecast (2017-2027)

9.2.2.  Europe E-Pharmacy Market Forecast (2017-2027)

9.2.2.1.  Germany E-Pharmacy Market Forecast (2017-2027)

9.2.2.2.  France E-Pharmacy Market Forecast (2017-2027)

9.2.2.3.  UK E-Pharmacy Market Forecast (2017-2027)

9.2.2.4.  Russia E-Pharmacy Market Forecast (2017-2027)

9.2.2.5.  Italy E-Pharmacy Market Forecast (2017-2027)

9.2.2.6.  Rest of Europe E-Pharmacy Market Forecast (2017-2027)

9.2.3.  Asia-Pacific E-Pharmacy Market Forecast (2017-2027)

9.2.3.1.  China E-Pharmacy Market Forecast (2017-2027)

9.2.3.2.  Japan E-Pharmacy Market Forecast (2017-2027)

9.2.3.3.  Korea E-Pharmacy Market Forecast (2017-2027)

9.2.3.4.  India E-Pharmacy Market Forecast (2017-2027)

9.2.3.5.  Southeast Asia E-Pharmacy Market Forecast (2017-2027)

9.2.3.6.  Rest of Asia-Pacific E-Pharmacy Market Forecast (2017-2027)

9.2.4.  South America E-Pharmacy Market Forecast (2017-2027)

9.2.4.1.  Brazil E-Pharmacy Market Forecast (2017-2027)

9.2.4.2.  Argentina E-Pharmacy Market Forecast (2017-2027)

9.2.4.3.  Columbia E-Pharmacy Market Forecast (2017-2027)

9.2.4.4.  Rest of South America E-Pharmacy Market Forecast (2017-2027)

9.2.5.  Middle East and Africa E-Pharmacy Market Forecast (2017-2027)

9.2.5.1.  Saudi Arabia E-Pharmacy Market Forecast (2017-2027)

9.2.5.2.  United Arab Emirates E-Pharmacy Market Forecast (2017-2027)

9.2.5.3.  Egypt E-Pharmacy Market Forecast (2017-2027)

9.2.5.4.  Nigeria E-Pharmacy Market Forecast (2017-2027)

9.2.5.5.  South Africa E-Pharmacy Market Forecast (2017-2027)

9.2.5.6.  Turkey E-Pharmacy Market Forecast (2017-2027)

9.2.5.7.  Rest of Middle East and Africa E-Pharmacy Market Forecast (2017-2027)

9.3.     E-Pharmacy Market Forecast by Product Type (2017-2027)

9.3.1.  E-Pharmacy Forecast by Product Type (2017-2027)

 

9.3.2.  E-Pharmacy Market Share Forecast by Product Type (2017-2027)

---

List of Tables

*You can glance through the list of Tables and Figures when you view the sample copy of EPharmacy Market.

---

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix	Supply Side	Demand Side
Primary Data Sources	Manufacturers Distributors & Wholesalers GPOs	Physicians/Specialist Healthcare Providers Consumers
Secondary Data Sources	Annual Reports/SEC Filings/ Investor Presentations/ Press Releases Government/Associations Publications	Case Studies Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

• Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:

• Number of patients for particular device or medical procedure and
• Repeated use of particular device depending on health and condition of patient

• Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data	Quantitative Data (2017-2025)
Market Dynamics (Drivers, Restraints, and Challenges) Industry Trend Analysis Market Opportunities Government Policies and Regulations, Patent Analysis, and Reimbursement Policies Porter’s Five Forces and PESTLE Analysis Key Developments and Competitive Landscape	Market Assessment and Forecast Market Assessment and Forecast, By Product Market Assessment and Forecast, By Technology Market Assessment and Forecast, By Application Market Assessment and Forecast, By End User Market Assessment and Forecast, By Region/Country